Yes, I imagine they would've PR'd if injected unde

Yes, I imagine they would've PR'd if injected under the naive trial protocol for mTNBC.....my guess is they have additional emergency patients......whether this be mTNBC, colon, or other cancer I don't know, but my guess is they have injected a colon cancer patient. I don't see a need for them to PR additional patients under the emergency protocol other than the subtle hints NP has given in the last 2 colon cancer PRs. Maybe I'm being too optimistic with this guess, but to me it makes no sense to thank patients for their participation in previous HIV trials when this and the previous PR is only discussing colon cancer....the first PR from 8 August when they filed the colon IND thanked them and was questionable and I could believe this was a mistake or poorly worded for HIV, but not when it happened again in the next colon cancer PR.

Even if only emergency patients at this point, IMO that is good for a few reasons: 1) hopefully this significantly helps the patients desperately in need, 2) establish patients and any positive results, word will spread and people will be lining up to participate in the official trials and 3) with additional patients we will eventually get interim results, so the sooner the better on all fronts, and 4) FDA may act quickly if proven to help very sick patients. We are not there yet, but additional patients could be a big step in getting there pretty soon.

As misiu mentioned, it is impressive that this IND was approved in ~31 calendar days from being filed when RP couldn't even get it filed in several months.

8 August PR:
https://www.cytodyn.com/newsroom/press-releas...he-fda-for

Please do your own due diligence. All my posts and comments are not to be considered investment advice.